Sentinus LLC’s Amgen AMGN Stock Holding History

Sentinus LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Buy	3,305 +1,168	+55%	+$416K	0.11%	155
2025 Q4	$700K	Buy	+2,137	New	+$678K	0.07%	223
2025 Q2	–	Sell	-645	Closed	-$201K	–	212
2025 Q1	$201K	Buy	+645	New	+$190K	0.06%	189

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sentinus LLC's AMGN Position: Q1 2026 in Review

Sentinus LLC increased its Amgen (AMGN) stake by 55% in Q1 2026, buying an estimated $416K and bringing the position to 3,305 shares worth $1.16M. The position accounts for 0.11% of the portfolio, ranked #155.

Sentinus LLC first reported a position in AMGN in Q1 2025 and has held it in 3 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Sentinus LLC held 3,305 shares of Amgen worth $1.16M as of Q1 2026.
Sentinus LLC bought 1,168 Amgen shares in Q1 2026, an estimated $416K.
Amgen made up 0.11% of Sentinus LLC's portfolio in Q1 2026, its #155 holding.
Sentinus LLC first reported a position in Amgen in Q1 2025 and has held it in 3 quarters since.
3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.